ArticleAging medicine (Milton (N.S.W))2025
Analysis of Outcomes in Pancreaticoduodenectomy for Elderly Patients Aged 80 and Above: A Retrospective Study Using Inverse Probability of Treatment Weighting.
Article in Aging medicine (Milton (N.S.W)), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: With an aging population, more elderly individuals are facing the decision to undergo complex surgeries, such as pancreaticoduodenectomy (PD). This study evaluates the safety and feasibility of PD in patients aged 80 and above. Methods: We conducted a retrospective analysis of 422 patients who underwent PD between August 2011 and January 2024. The patients were categorized into three age groups: < 60 years, 60-79 years, and ≥ 80 years. We adjusted for baseline characteristics using inverse probability of treatment weighting (IPTW) and compared postoperative complications, hospital stay durations, 90-day mortality, and long-term survival across the groups. A subgroup analysis identified factors associated with complications and 90-day mortality. Results: After IPTW adjustment, no significant differences in complications or long-term survival were observed between the groups. However, the ≥ 80-year group had a significantly higher 90-day mortality rate (13.64%) compared to the 60-79 years group (2.00%) and the < 60 years group (1.46%) ( Conclusions: Age does not significantly impact postoperative complications or long-term survival following PD. While PD is safe and feasible for the elderly, those with cardiovascular comorbidities or poor nutritional status face higher risks of complications and mortality. A comprehensive preoperative assessment is critical to minimizing these risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.